Osteoarthritis

Related records

Broader conditions (11)

• Arthritic joint disease
• Arthropathy
• Bone disorder
• Bone inflammation disease
• Disease
• Disease by body system or component
• Disease by developmental or physiological process
• Human disease
• Inflammatory disease
• Musculoskeletal system disorder
• Skeletal system disorder

Narrower conditions (5)

• Osteoarthritis, hand
• Osteoarthritis, hip
• Osteoarthritis, knee
• Osteoarthritis, spine
• Osteoarthritis, toe

Trials (2,677)

• "Bimodal vs Unimodal High-Intensity Pulsed Electromagnetic Field Therapy in Older Adults With Knee Osteoarthritis"
• "Blind" vs. Fluoroscopy-Guided Steroid Injections for Knee Osteoarthritis
• "Effectiveness of Mulligan Mobilization Technique and Proprioceptive Exercises Among Patients With Knee Osteoarthritis"
• "Ready-to-use" Intra-articular Formulation of Mesenchymal Stromal Cells
• "Score Infectivity" During Reoperation on Total Hip or Knee Prosthesis
• "Transarterial Microembolization (TAME) in Inflammatory Knee Pathology"
• "Translating Articular Biomarkers Into Diagnoses"
• 10003 PRO Current Products
• 12-Week No-Rofecoxib Plus Aspirin Endoscopy Study (0782-003)
• 14022 ATTUNE Cementless RP Clinical Performance Evaluation
• 15-Hydroxyprostaglandin Dehydrogenase in Osteoarthritis and Ankylosing Spondylitis
• 2 Weekly Intra-articular Hyaluronan Knee Injections, Given 1 wk. Apart, of HYMOVIS Combined With Physical Exercise Program (PEP) Compared to PEP Alone, in Relatively Young, Active Population of Subjects With Patellofemoral Osteoarthritis (PFOA) and/or Tibiofemoral Osteoarthritis (TFOA)
• 2-Year Post-Approval Study to Investigate the Scandinavian Total Ankle Replacement System (STAR) Ankle Under Actual Conditions of Use
• 26 Week Open Label Study Evaluating Single IA Injection of DUROLANE SJ for Treatment of Osteoarthritis Pain of the Ankle
• 28mm Ceramic-on-Ceramic Total Hip Replacement Study
• 2ccPA Study in Patients With Symptomatic Knee Osteoarthritis
• 3-year, Open-Label Study Evaluating Safety, Tolerability, and Efficacy of Lorecivivint in Knee Osteoarthritis
• 3VM for Treatment of Chronic Osteoarthritis Knee Pain
• 52 Week, International, Multi-center, Randomized, Double-blind, Double-dummy, Parallel-group Clinical Trial to Compare Retention on Treatment, Safety, Tolerability & Efficacy of Lumiracoxib 100 mg od, Lumiracoxib 100 mg Bid & Celecoxib 200 mg od in Pts With Primary OA of Hip, Knee, Hand or Spine
• 53-Week Study Evaluating the Safety and Efficacy of Intra-articular Injections of TPX-100 With Mild to Severe Tibio-Femoral Osteoarthritis of the Knee

Approved drugs (39)

• Aceclofenac
• Amlodipine besylate
• Capsaicin
• Celecoxib
• Cortisone acetate
• Dexamethasone
• Dexamethasone sodium phosphate
• Diclofenac
• Diclofenac potassium
• Diclofenac sodium
• Diflunisal
• Esomeprazole magnesium
• Etodolac
• Famotidine
• Fenoprofen calcium
• Hydrocortisone
• Ibuprofen
• Indomethacin
• Ketoprofen
• Lidocaine

Drugs in development (122)

• Acetaminophen Phase 3
• Adalimumab Phase 3
• AGG-523 Phase 1
• Aldumastat Phase 2
• Alendronic acid Phase 2
• Allopurinol Phase 1
• AMG-108 Phase 2
• Amobarbital Phase 1
• Anakinra Phase 2
• ARRY-797 Phase 2
• Ascorbic acid Phase 1
• Aspirin Phase 3
• ATB-346 Phase 2
• Autologous adipose-derived stromal vascular fraction Phase 1
• Betamethasone acetate Phase 3
• Betamethasone sodium phosphate Phase 3
• BI113823 Phase 1
• BMS-986142 Phase 1
• Bupivacaine Phase 3
• Buprenorphine Phase 3

Other linked drugs (11)

• Choline magnesium trisalicylate
• Curcuminoids
• Diphenhydramine
• Esflurbiprofen
• Flurbiprofen
• Hylan G-F 20
• Isoxicam
• Metformin hydrochloride
• Nepafenac
• Proglumetacin
• Proquazone